Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney diseaseMichelle Kwon, Tengis S Pavlov, Kandai Nozu, et al.European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesionsH M Verkooijen, J L Peterse, M E I Schipper, et al.Circulation|May 9, 2013
Histopathology of embolic debris captured during transcatheter aortic valve replacementNicolas M Van Mieghem, Marguerite E I Schipper, Elena Ladich, et al.Nature Genetics|December 2, 2000
A point mutation in PTPRC is associated with the development of multiple sclerosisM Jacobsen, D Schweer, A Ziegler, et al.Gut|March 14, 2008
High frequency of early colorectal cancer in inflammatory bowel diseaseM W M D Lutgens, F P Vleggaar, M E I Schipper, et al.Plos One|December 4, 2014
Impact of global Fxr deficiency on experimental acute pancreatitis and genetic variation in the FXR locus in human acute pancreatitisRian M Nijmeijer, Frank G Schaap, Alexander J J Smits, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2015
Activator of G-Protein Signaling 3-Induced Lysosomal Biogenesis Limits Macrophage Intracellular Bacterial InfectionAli Vural, Souhaila Al-Khodor, Gordon Y C Cheung, et al.Plos One|January 4, 2013
Development of a real-time PCR for identification of brachyspira species in human colonic biopsiesLaurens J Westerman, Herbert V Stel, Marguerite E I Schipper, et al.Annals of Surgical Oncology|January 8, 2015
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinomaP C van der Sluis, I Ubink, S van der Horst, et al.Gut|January 19, 2011
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel diseaseRaffaella M Gadaleta, Karel J van Erpecum, Bas Oldenburg, et al.Pageof 21